Literature DB >> 10333721

Intermittent parathyroid hormone treatment can promote linear growth in the ovariectomized growing rat.

S K Lim1, Y J Won, D H Park, D H Shin, J I Yook, H C Lee, K B Huh.   

Abstract

To compare the effect of intermittent parathyroid hormone (PTH) treatment with that of estrogen treatment on epiphyseal growth in ovariectomized rats, 46 Sprague-Dawley female rats aged 9-10 weeks (about 200-220 g) were either ovariectomized or sham operated. From 6 weeks after ovariectomy (ovx), rats were daily injected with subcutaneous human recombinant PTH (1-84)-dosed 30 micrograms/kg (the low dose PTH-treated group) or 300 micrograms/kg (the high dose PTH-treated group), 17 beta-estradiol (the 17 beta-estradiol-treated group, 30 micrograms/kg) or vehicle (the ovx-alone group), 5 times a week for 4 weeks. The decalcified sections of the distal femoral epiphyseal plate were analyzed on light microscopy after H&E stain, and the lengths of the zones of proliferation, maturing and hypertrophic chondrocytes were measured. The length of the growth plate, the zone of proliferation and the zone of hypertrophic chondrocyte in the ovx-alone group were significantly shorter than those of the sham-operated group. The treatment of 17 beta-estradiol speeded up the differentiation of cells from proliferating chondrocytes to maturing and hypertrophic chondrocytes even though the length of the growth plate was comparable to that of the sham-operated group. Both low and high dose PTH treatments increased the length of the growth plate, and those lengths were comparable to that of the sham-operated group. The fractions of proliferating, maturing and hypertrophic zone in the low dose PTH-treated group were also comparable to those of the sham-operated group. However, high dose PTH treatment slowed down the differentiation of cells from proliferating chondrocytes to maturing and hypertrophic chondrocytes to a greater extent, and therefore the fraction of proliferating chondrocytes of the high dose PTH-treated group was larger than that of the low dose PTH-treated group (73.8 +/- 1.8 Vs 63.3 +/- 1.3%, p < 0.005). From these results, we showed that intermittent PTH treatment could promote linear growth in the ovariectomized growing rat. We propose that PTH may be an alternative drug candidate for promoting linear growth of long bones without the risk for early closure of the growth plate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333721     DOI: 10.3349/ymj.1999.40.2.166

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  3 in total

1.  Quantification of skeletal growth, modeling, and remodeling by in vivo micro computed tomography.

Authors:  Allison R Altman; Wei-Ju Tseng; Chantal M J de Bakker; Abhishek Chandra; Shenghui Lan; Beom Kang Huh; Shiming Luo; Mary B Leonard; Ling Qin; X Sherry Liu
Journal:  Bone       Date:  2015-08-06       Impact factor: 4.398

2.  PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.

Authors:  Todd A Theman; Michael T Collins; David W Dempster; Hua Zhou; James C Reynolds; Jaime S Brahim; Paul Roschger; Klaus Klaushofer; Karen K Winer
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

3.  Rolipram, a phosphodiesterase 4 inhibitor, stimulates inducible cAMP early repressor expression in osteoblasts.

Authors:  Eun Sook Cho; Ja Heon Yu; Mi Sun Kim; Mijung Yim
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.